Malignant pleural mesothelioma in situ

Although the diagnosis of malignant pleural mesothelioma at an in situ stage was traditionally challenging, it is now possible owing to advances in molecular biological methods such as P16 fluorescence in situ hybridization or BRCA1-associated protein 1 immunohistochemistry. Here, we report the firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Kohei, Morohoshi, Takao, Tsuura, Yukio, Masuda, Munetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639806/
https://www.ncbi.nlm.nih.gov/pubmed/36205712
http://dx.doi.org/10.1093/icvts/ivac255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639806/
https://www.ncbi.nlm.nih.gov/pubmed/36205712
http://dx.doi.org/10.1093/icvts/ivac255

Ejemplares similares